8-K Announcements
6Material company update
May 15, 2026·SEC
Material company update
May 13, 2026·SEC
Material company update
Apr 10, 2026·SEC
Retractable Technologies, Inc.(RVP)Earnings, Financials & Key Ratios
RVP•AMEX
$0.71
Price updated Jul 7, 2026
AboutRetractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. The company distributes its products through general line and specialty distributors, as well as through international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.Show more
- Revenue$38M+15.8%
- EBITDA-$12M+8.0%
- Net Income-$13M-5.7%
- EPS (Diluted)-0.43-7.5%
- Gross Margin0.12%+104.0%
- EBITDA Margin-32.55%+20.5%
- Operating Margin-52.84%+17.3%
- Net Margin-32.84%+8.7%
- ROE-15.56%-22.0%
RVP Price & Volume
Retractable Technologies, Inc. (RVP) stock price & volume — 10-year historical chart
Loading chart...
Structural Margin Erosion Threatens Retractable Technologies Solvency
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Decelerating
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Liquidity and operational insolvency
Key Thesis Takeaways
- Retractable Technologies faces a critical inflection point as its core medical device business struggles with a 13.5% year-over-year revenue contraction and a near-zero gross margin of 0.3%.
- The company's reliance on lumpy, unpredictable government procurement cycles has failed to provide the necessary scale to offset high fixed operating costs, leading to persistent net losses.
- Investors should remain cautious as the rapid depletion of cash reserves, which fell from $12.7M in 2023Q4 to $2.8M in 2026Q1, suggests an urgent need for capital restructuring or a fundamental shift in operational strategy.
Verdict Logic
the company's cash runway has dwindled to $2.8M, and the persistent inability to generate positive free cash flow, highlighted by a -63.0% FCF margin in 2024Q3, presents an unacceptable risk of operational insolvency.
RVP Growth Metrics
Retractable Technologies, Inc. (RVP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years2.62%
5 Years-14.11%
3 Years-26.1%
TTM10.08%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM72.43%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM72.27%
Return on Capital
10 Years4.67%
5 Years4.6%
3 Years-11.17%
Last Year-14.19%
RVP Recent Earnings
Retractable Technologies, Inc. (RVP) EPS & revenue vs analyst estimates — last 4 quarters
●Beat Revenue 0/12 qtrs (0%)
Q2 2026Latest
May 15, 2026Metric
Actual
Est
EPS
$0.14
—
Rev
$7M
—
Q2 2026
Mar 27, 2026Metric
Actual
Est
EPS
$0.08
—
Rev
$9M
—
Q4 2025
Nov 14, 2025Metric
Actual
Est
EPS
$0.01
—
Rev
$10M
—
Q3 2025
Aug 14, 2025Metric
Actual
Est
EPS
$0.12
—
Rev
$10M
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.14 | $7M |
| Q2 2026 | Mar 27, 2026 | $0.08 | $9M |
| Q4 2025 | Nov 14, 2025 | $0.01 | $10M |
| Q3 2025 | Aug 14, 2025 | $0.12 | $10M |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Retractable Technologies, Inc. (RVP)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.71 | $21.29M | -1.65 | 15.78% | -32.84% | -15.56% | 1.08% | |
| $3.49 | $184.18M | -3.26 | -9.06% | -8.03% | -22.93% | — | |
| $72.14 | $4.3B | 33.87 | 11.66% | 9.03% | 8.95% | — | |
| $69.33 | $220.75M | 19.92 | -5.83% | 28.9% | 9.13% | — | |
| $17.72 | $2.02B | -14.52 | 8.28% | -25.66% | -50.82% | — | |
| $39.70 | $1.38B | 47.26 | 36.31% | 2.96% | 8.42% | — |
Compare RVP vs Peers
Retractable Technologies, Inc. (RVP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
RVP SEC Filings & Documents
Retractable Technologies, Inc. (RVP) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when RVP posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
RVP Frequently Asked Questions
Retractable Technologies, Inc. (RVP) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Retractable Technologies, Inc.'s revenue?
Retractable Technologies, Inc. (RVP) reported $37.1M in revenue for fiscal year 2025. This represents a 285% increase from $9.6M in 2000.
How fast is Retractable Technologies, Inc. growing?
Retractable Technologies, Inc. (RVP) grew revenue by 15.8% over the past year. This is strong growth.
Is RVP profitable?
Retractable Technologies, Inc. (RVP) reported a net loss of $6.3M for fiscal year 2025.
Dividend & Returns
Does RVP pay dividends?
Yes, Retractable Technologies, Inc. (RVP) pays a dividend with a yield of 1.08%. This makes it attractive for income-focused investors.
What is RVP's return on equity?
Retractable Technologies, Inc. (RVP) has a return on equity (ROE) of -15.6%. Negative ROE indicates the company is unprofitable.
What is Retractable Technologies, Inc.'s free cash flow?
Retractable Technologies, Inc. (RVP) had negative free cash flow of $7.4M in fiscal year 2025, likely due to heavy capital investments.